Molecular and Cellular Biochemistry

, Volume 258, Issue 1–2, pp 137–144

β-Criptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro

  • Masayoshi Yamaguchi
  • Satoshi Uchiyama
Article

Abstract

The effect of β-cryptoxanthin, which is greatly present in fruits, has not been clarified so far on bone metabolism. The effect of β-cryptoxanthin on bone formation and bone resorption was investigated in tissue culture in vitro. Rat femoral-diaphyseal (cortical bone) and -metaphyseal (trabecular bone) tissues were cultured for 48 h in Dulbecco's modified Eagle's medium (high glucose, 4.5%) supplemented with antibiotics and bovine serum albumin. The experimental cultures contained 10–8–10–5 M β-cryptoxanthin. The presence of β-cryptoxanthin (10–6 or 10–5 M) caused a significant increase in calcium content, alkaline phosphatase activity and deoxyribonucleic acid (DNA) content in the diaphyseal and metaphyseal tissues. These increases were completely prevented in the presence of cycloheximide (10–6 M), an inhibitor of protein synthesis. β-Carotene (10–6 or 10–5 M) or xantine (10–6 or 10–5 M) had no effect on the diaphyseal and metaphyseal calcium contents. The bone-resorbing factors parathyroid hormone (1–34) (PTH; 10–7 M) or prostaglandin E2 (PGE2; 10–5 M) caused a significant decrease in calcium content in the diaphyseal and metaphyseal tissues. The decrease in bone calcium content induced by PTH or PGE2 was completely inhibited by β-cryptoxanthin (10–8−10–6 M). In addition, β-cryptoxanthin (10–8−10–6 M) completely inhibited the PTH (10–7 M)- or PGE2 (10–5 M)-induced increase in medium glucose consumption and lactic acid production by diaphyseal and metaphyseal tissues. The inhibitory effect of β-cryptoxanthin (10–7 M) on PTH (10–7 M)- or PGE2 (10–5 M)-stimulated decrease in the diaphyseal calcium content was significantly prevented in the presence of 10–3 M vanadate, an inhibitor of protein tyrosine phosphatase. Vanadate (10–3 M) did not have a significant effect on calcium content and lactic acid production in control bone tissues. The present study demonstrates that β-cryptoxanthin has a direct stimulatory effect on bone formation and an inhibitory effect on bone resorption in tissue culture in vitro.

β-cryptoxanthin bone formation bone resorption rat femur tissue culture 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nishimoto SK, Chang C-H, Gendler E, Stryker WF, Nimni ME: The effect of aging on bone formation in rats: Biochemical and histological evidence for decreased bone formation capacity. Calcif Tissue Int 37: 617–624, 1985Google Scholar
  2. 2.
    Schapira C, Slinn S, Sarid M, Mokadi S, Kabala A, Silbermann M: Calcium and vitamin D enriched diets increase and preserve vertebral mineral content in aging laboratory rats. Bone 16: 575–582, 1995Google Scholar
  3. 3.
    Wild RA, Buchamain JR, Myers C, Demers LM: Declining adrenal androgen; an association with bone loss in aging women. Proc Soc Exp Biol Med 186: 335–360, 1987Google Scholar
  4. 4.
    Cooper C, Melton J III: Epidemiology of osteoporosis. Trends Endocrinol Metab 3: 224–229, 1995Google Scholar
  5. 5.
    Bonjour J-P, Schurch M-A, Rozzori R: Nutritional aspects of hip fractures. Bone 18: 1395–1445, 1996Google Scholar
  6. 6.
    Sugimoto E, Yamaguchi M: Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5: 515–520, 2000Google Scholar
  7. 7.
    Sugimoto E, Yamaguchi M: Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem Pharmacol 59: 471–475, 2000Google Scholar
  8. 8.
    Yamaguchi M, Gao YH: Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 55: 71–76, 1998Google Scholar
  9. 9.
    Gao YH, Yamaguchi M: Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 58: 767–772, 1999Google Scholar
  10. 10.
    Yamaguchi M: Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J Health Sci 48: 209–222, 2002Google Scholar
  11. 11.
    Price PA: Vitamin K-dependent formation of bone gla protein (osteocalcin) and its function. Vitam Horm 42: 65–108, 1985Google Scholar
  12. 12.
    Yamaguchi M, Sugimoto E, Hachiya S: Stimulatory effect of menaquinone-7 (vitamin K2) on osteoblastic bone formation in vitro. Mol Cell Biochem 223: 131–137, 2001Google Scholar
  13. 13.
    Yamaguchi M, Ma ZJ: Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro. Mol Cell Biochem 228: 39–47, 2001Google Scholar
  14. 14.
    Blair HC, Jordan SE, Pererson TG, Barnes S: Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61: 629–637, 1996Google Scholar
  15. 15.
    Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S: Selective effects of genisteon, a soybean isoflavone, on β-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140: 1893–1900, 1999Google Scholar
  16. 16.
    Yamaguchi M, Kakuda H, Gao YH, Tsukamoto Y: Prolonged intake of fermented soybean (natto) diets containing vitamin K2 (menaquinone-7) prevents bone loss in ovariectomized rats. J Bone Miner Metab 18: 71–76, 2000Google Scholar
  17. 17.
    Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M: Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and γ-carboxylated osteocalcin concentration in normal individuals. J Bone Miner Metab 18: 216–222, 2000Google Scholar
  18. 18.
    Stenmetz KA, Potter JD: Vegetable, fruits, and cancer prevention: A review. J Am Diet Assoc 96: 1027–1033, 1996Google Scholar
  19. 19.
    Yamaguchi M, Oishi H, Suketa Y: Stimulatory effect of zinc on bone formation in tissue culture. Biochem Pharmacol 36: 4007–4012, 1987Google Scholar
  20. 20.
    Walter K, Schutt C: Acid and alkaline phosphatase in serum. In: H.U. Bergmeyer (ed). Methods of Enzymatic Analysis, Vols 1–2. Academic Press, New York, 1965, pp 856–860Google Scholar
  21. 21.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951Google Scholar
  22. 22.
    Flangan B, Nichols G Jr: Metabolic studies of bone in vitro. IV. Collagen biosynthesis by surviving bone fragments in vitro. J Biol Chem 237: 3686–3692, 1962Google Scholar
  23. 23.
    Ceriotti G: Determination of nucleic acids in animal tissues. J Biol Chem 214: 39–77, 1955Google Scholar
  24. 24.
    Hyvarimem A, Nikkila EA: Specific determination of blood glucose with o-toludine. Clin Chim Acta 7: 140–143, 1962Google Scholar
  25. 25.
    Noll F: Determination with LDH, GPT and NAD. In: H.U. Bergmeyer (ed). Methods of Enzymatic Analysis, Vol 3, Academic Press, New York, 1965, pp 1475–1479Google Scholar
  26. 26.
    Hunter T: Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80: 225–236, 1995Google Scholar
  27. 27.
    Komm BS, Terpening CM, Beng DJ, Graema KA, Gallegos A, Korc M, Greene GC, O'Malley BW, Haussler MR: Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241: 81–83, 1988Google Scholar
  28. 28.
    Erikson EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL: Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84–86, 1988Google Scholar
  29. 29.
    Centralla M, McCarthy TL, Canalis E: Receptors for insulin-like growth factor-I and-II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 126: 39–44, 1990Google Scholar
  30. 30.
    Machwate M, Zerath E, Holy X, Pastoureau P, Marie PJ. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology 134: 1031–1038, 1994Google Scholar
  31. 31.
    Klein-Nulend J, Fall PM, Raisz LG: Comparison of the effects of synthetic human parathyroid hormone (PTH)-(1-34)-related peptide of malignancy and bovine PTH-(1-34) on bone formation and resorption in organ culture. Endocrinology 126: 223–227, 1990Google Scholar
  32. 32.
    Graves L III, Jilka RL: Comparison of bone and parathyroid hormone as stimulators of osteoclast development and activity in calvarial cell cultures from normal and osteopetrotic (mi/mi) mice. J Cell Physiol 145: 102–109, 1990Google Scholar
  33. 33.
    Klein DC, Raisz LG: Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology 86: 1436–1440, 1970Google Scholar
  34. 34.
    Vaes G: On the mechanisms of bone resorption. The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells. J Cell Biol 39: 676–697, 1968Google Scholar
  35. 35.
    Aoki K, Didomenico E, Sims NA, Mukhonpadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R: The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in mev/mev mutant mice. Bone 25: 261–267, 1999Google Scholar
  36. 36.
    Missbach M, Jeschke M, Feyen J, Muller K, Glatt M, Green J, Susa M: A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone 24: 437–449, 1999Google Scholar
  37. 37.
    McEligot AJ, Rock CL, Shanks TG, Flatt SW, Newman V, Faerber S, Pierce JP: Comparison of serum carotenoid responses between women consuming vegetable juice and woman consuming raw or cooked vegetable. Cancer Epideminol Biomark Prev 8: 227–231, 1999Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Masayoshi Yamaguchi
    • 1
  • Satoshi Uchiyama
    • 1
  1. 1.Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional SciencesUniversity of ShizuokaShizuokaJapan

Personalised recommendations